Rwandan health authorities have taken swift action following safety concerns surrounding antifungal tablets produced in Kenya.
The Rwanda Food and Drugs Authority (RFDA) issued a recall notice for all batches of 200 mg Fluconazole tablets manufactured by the Kenyan company Universal Corporation.
The directive, aimed at importers, mandates the return of these tablets due to discolouration issues discovered by the RFDA.
Specifically, four bulk batches of pink Fluconazole 200mg tablets showed white discolouration shortly after their shelf life began once imported into Rwanda.
Highlighting the urgency of the situation, the RFDA emphasized that some of these discoloured tablets had already entered the Rwandan market.
Consequently, retailers and health facilities have been instructed to cease distribution and return the affected drugs immediately.
As a precautionary measure, health officials in Rwanda have launched an investigation to ascertain whether these potentially compromised drugs have caused any adverse effects among consumers.
Amid these developments, Kenyan authorities are yet to announce whether the same antifungal drug, commonly used to treat fungal or yeast infections, will also undergo a recall within the local market.
Read: Ned Nwoke: Nigerians Should Be Allowed to Carry Guns
About The Author
Related Articles
Senegal’s Power Cuts Force Government to Push Gas as the Long-Term Fix
Senegal’s energy minister says the power cuts that hit the country hard...
Ethiopia and Eritrea Cut Diplomatic Ties as Tigray Conflict Escalates
Ethiopia and Eritrea have severed diplomatic relations as renewed fighting in northern...
Tinubu Cannot Even Speak for Himself, Nigerians Say After Edited Broadcast Exposed
Nigerians on social media have accused the Presidency of manipulating President Bola...
Tinubu’s Cancer Analogy Backfires as Nigerians Remind Him He Was in Power Since 2015
President Bola Tinubu’s attempt to paint himself as the leader who inherited...